| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 04/11/2006 | US7026486 Process for production cilostazol |
| 04/11/2006 | US7026476 Intermediate arylamine compounds |
| 04/11/2006 | US7026350 Water-soluble drugs and methods for their production |
| 04/11/2006 | US7026349 Sulfonamides |
| 04/11/2006 | US7026346 Anticancer agents |
| 04/11/2006 | US7026336 4-pyridinylimidazol-2-ylhydrocarbyl amine, (thio)urea, carbamic acid or sulfonamide derivatives, e.g., (2-(4-(4-Chloro-3-methoxy-phenyl)-5-pyridin-4-yl-1H-imidazol-2-yl)-2-methyl-propyl)-carbamic acid tert-butyl ester; Raf kinase inhibitors for the treatment of neurotraumatic diseases |
| 04/11/2006 | US7026328 Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins |
| 04/11/2006 | US7026325 pyrazinoylguanidine compounds, e.g., 4-{4-[N-(3,5-diamino-6-chloropyrazine-2-carbonyl)guanidino]butyl}-N-(2-aminoethyl)benzamide hydrochloride; are absorbed less rapidly from mucosal surfaces, especially airway surfaces; rehydration of mucosal surfaces; reducing blood pressure |
| 04/11/2006 | US7026324 Amide containing a pyridinone or pyrazinone compound as serine protease enzyme inhibitors |
| 04/11/2006 | US7026322 Anticancer agents; fungicides |
| 04/11/2006 | US7026318 Compounds exhibiting X-type sPLA2 inhibiting effect |
| 04/11/2006 | US7026314 Psychological disorders, antidepressants, anxiolytic agents, eating disorders; serotonin receptors antagonist |
| 04/11/2006 | US7026310 Heteroaryl derivatives and their use as medicaments |
| 04/11/2006 | US7025949 In-vivo diagnostic method by means of near infrared radiation |
| 04/11/2006 | CA2162382C Intercalators having affinity for dna and methods of use |
| 04/06/2006 | WO2006037117A1 Substituted heterocyclic compounds and methods of use |
| 04/06/2006 | WO2006036981A2 Small molecule modulators of cytokine activity |
| 04/06/2006 | WO2006036507A1 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | WO2006036024A1 Proton pump inhibitors |
| 04/06/2006 | WO2006035068A2 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 04/06/2006 | WO2006035067A2 Hiv inhibiting 5-heterocyclyl pyrimidines |
| 04/06/2006 | WO2006034833A1 Cyclic diarly ureas suitable as tyrosine kinase inhibitors |
| 04/06/2006 | WO2006034804A1 Indozolone derivatives as 11b-hsd1 inhibitors |
| 04/06/2006 | WO2005081687A3 Human hinge core mimetibodies, compositions, methods and uses |
| 04/06/2006 | US20060074247 Improving storage stability by reacting with hydrogen sulfate lithium- containing compound; aspartyl protease inhibitors |
| 04/06/2006 | US20060074245 Reacting a 5-( beta -ketoalkyl)-3-substituted-1,2,4-oxadiazoles compound with hydrazine |
| 04/06/2006 | US20060074244 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway |
| 04/06/2006 | US20060074238 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates |
| 04/06/2006 | US20060074123 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/06/2006 | US20060074122 e.g., N-butyl-6-chloro-5-phenyl-1H-indazol-3-amine; kinase inhibitor; obesity and stroke; diseases involving phosphorylation of the tau protein such as Alzheimer's disease, Parkinson's disease, frontoparietal dementia |
| 04/06/2006 | US20060074120 cyclopent[f]pyrazole derivatives; antiinflammatory agent; autoimmune diseases; side effect reduction, advantages over steroidal glucocorticoid ligands with respect to undesireable side-effects, efficacy, toxicity or metabolism |
| 04/06/2006 | US20060074117 Purification of olmesartan medoxomil |
| 04/06/2006 | US20060074116 3-(Heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 04/06/2006 | US20060074096 anti-cell prolifertive agents; 4-(1,2-diethylimidazol-5-yl)-2-{4-[N-(2-ethoxyethyl)sulphamoyl]anilino}pyrimidine; cancers, solid tumours, leukemias, psoriasis, rheumatoid arthritis, Kaposi's sarcoma, hemangioma, nephropathies, atheroma, atherosclerosis, restenosis, autoimmune diseases, inflammation |
| 04/06/2006 | US20060074092 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin K inhibitory activity for the treatment of inflammations and other diseases |
| 04/06/2006 | US20060074084 Inhibitors of soluble adenylate cyclase |
| 04/06/2006 | US20060074075 including cystic fibrosis transmembrane conductance regulator ("CFTR"), used for treating genetic disorders; respiratory system disorders |
| 04/06/2006 | US20060074072 2-[3-(4-chlorophenyl)ureido] N-[4-(2-oxo-2H-pyridin-1-yl)phenyl]-4-methanesulfonylbutyramide; prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors |
| 04/06/2006 | US20060074069 e.g. (2R-trans) [4-(4-azetidin-3-yl-piperazin-1-yl)-2-benzyl-piperidin-1-yl]-(3,5-bis-trifluoromethyl-phenyl)-methanone;tachykinins, substance P inhibitor; antidepressant, anxiolytic, antiinflammatory agent, cognition activator; neurodegenerative diseases; addiction, sleep, eating disorders |
| 04/06/2006 | US20060074068 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions |
| 04/06/2006 | US20060073472 Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
| 04/06/2006 | US20060070549 Self-dispersible colorant and ink composition containing the same |
| 04/06/2006 | DE60202958T2 Stabiles polymorph von flibanserin, industrielles verfahren zu dessen herstellung und dessen verwendung zur herstellung von medikamenten Stable polymorph of flibanserin, industrial process for its production and its use for the preparation of medicaments |
| 04/06/2006 | DE102004047272A1 Inhibitoren der löslichen Adenylatzyklase Inhibitors of soluble adenylate cyclase |
| 04/06/2006 | DE102004044829A1 5-Heterocyclylpyrimidine 5-Heterocyclylpyrimidine |
| 04/06/2006 | CA2582777A1 Proton pump inhibitors |
| 04/06/2006 | CA2581828A1 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 04/06/2006 | CA2580838A1 Substituted heterocyclic compounds and methods of use |
| 04/06/2006 | CA2579240A1 Small molecule modulators of cytokine activity |
| 04/06/2006 | CA2577185A1 Cyclic diarly ureas suitable as tyrosine kinase inhibitors |
| 04/06/2006 | CA2573976A1 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 04/05/2006 | EP1642581A2 Treatment of retinal diseases with quinoxaline derivatives |
| 04/05/2006 | EP1641779A1 2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator. |
| 04/05/2006 | EP1641777A1 Indole derivatives with apoptosis-inducing effect |
| 04/05/2006 | EP1641764A1 5-membered heterocycle-based p38 kinase inhibitors |
| 04/05/2006 | EP1641762A2 Cck-1 receptor modulators |
| 04/05/2006 | EP1641752A1 3- sulfonylamino- pyrrolidine- 2- one derivatives as inhibitors of factor xa |
| 04/05/2006 | EP1392308B1 Ophthalmically acceptable compositions comprising an alpha-2-adrenergic agonist and a fatty acid |
| 04/05/2006 | EP1377557B1 Methods of synthesizing heteroatom-bearing ligands and intermediate used therefor |
| 04/05/2006 | EP1300398B1 Propane-1,3-dione derivatives |
| 04/05/2006 | EP1140192B1 Use of the cyclooxygenase-2 inhibitor celecoxib and capecitabine for combination therapy in neoplasia |
| 04/05/2006 | EP1019372B1 Fused pyrrolecarboxamides; a new class of gaba brain receptor ligands |
| 04/05/2006 | CN1757066A Optical recording materials having high storage density |
| 04/05/2006 | CN1756754A Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 04/05/2006 | CN1756752A Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| 04/05/2006 | CN1756747A Anti-inflammatory medicaments |
| 04/05/2006 | CN1756734A Processes for producing glutamic acid derivative and pyroglutamic acid derivative and novel intermediate for production |
| 04/05/2006 | CN1756551A New arylpiperazinyl compounds |
| 04/05/2006 | CN1754880A Process for preparing 2-iminopyrrolidine derivatives |
| 04/05/2006 | CN1249056C Inhibitors of dipeptidyl peptidase IV |
| 04/05/2006 | CN1249055C Piperazinylcarbonylquinolines and -isoquinolines |
| 04/05/2006 | CN1249052C Pyrazole derivatives as HIV reverse transcriptase inhibitors |
| 04/05/2006 | CN1248683C Treatment of type 2 diabetes mellitus using inhibitors of dipeptidyl peptidase IV |
| 04/04/2006 | US7022851 A peptide nucleic acid derivatives comprising a N-acetyl-1-(2-nitro-phenensulfonyl)-peperazin-2-one core group; oligomerization, for specific binding to DNA as well as RNA, stability |
| 04/04/2006 | US7022849 Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 04/04/2006 | US7022808 Having plurality of 5-6 membered unsaturated rings linked together by way of linker chains to form a backbone, at least some of 5-6 membered unsaturated rings carrying a ligand; DNA mimics, supports for use in oligonucleotide production |
| 04/04/2006 | US7022730 Protein tyrosine phosphatases inhibitors |
| 04/04/2006 | US7022718 Pyridine and pyrimidine derivatives |
| 04/04/2006 | US7022717 Chemokine receptor binding heterocyclic compounds |
| 04/04/2006 | US7022716 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 04/04/2006 | US7022714 e.g., 3-(2-piperidinylethyl)-2-(4-phenoxyphenyl)benzimidazole and 3-(2-piperidinylethyl)-2-(N-ethyl-3-carbazolyl)benzimidazole; functions as an antitinnitus agent, anticonvulsant, antiarrhythmic, local anesthetic, or antimanic depressant. |
| 04/04/2006 | US7022708 Serotonin receptors antagonis; antidepressants; central nervous system disorders; Parkinson's disease; huntington's disease; Alzheimer's disease |
| 04/04/2006 | US7022696 Treatment of airway disorders |
| 04/04/2006 | US7022492 Ecstasy haptens and immunogens |
| 04/04/2006 | US7022143 Dyeing composition for dyeing keratinous fibers comprising a cationic azo-dye |
| 04/04/2006 | CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 04/04/2006 | CA2241787C Substituted aza- and diazacycloheptane and cyclooctane compounds and their use |
| 04/04/2006 | CA2198266C Novel benzimidazole derivatives |
| 04/04/2006 | CA2193039C Indol-2-one derivatives |
| 04/04/2006 | CA2166315C Process for the preparation of thalidomide |
| 04/04/2006 | CA2043976C Substituted phthalides and heterocyclic phthalides |
| 03/30/2006 | WO2006034474A2 Novel pyridine compounds, process for their preparation and compositions containing them |
| 03/30/2006 | WO2006034473A2 Novel pyrimidine compounds, process for their preparation and compositions containing them |
| 03/30/2006 | WO2006034440A2 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| 03/30/2006 | WO2006034419A2 Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
| 03/30/2006 | WO2006034391A2 Indole inhibitors of 15-lipoxygenase |
| 03/30/2006 | WO2006034338A1 Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase |
| 03/30/2006 | WO2006034116A1 Diaminotriazole compounds useful as protein kinase inhibitors |
| 03/30/2006 | WO2006033844A2 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide kcnq potassium channel modulators |
| 03/30/2006 | WO2006033620A1 New heterocyclic amides |